Teleflex (TFX) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Teleflex (TFX)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

178.99

0.45 (0.25%)

At close: Jan 14, 2025, 3:59 PM

179.17

0.10%

After-hours Jan 14, 2025, 07:00 PM EST

undefined% (undefined)

Bid	149.98
Market Cap	8.31B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	5.16
PE Ratio (ttm)	34.69
Forward PE	n/a
Analyst	Buy

Ask	196.4
Volume	295,383
Avg. Volume (20D)	465,667
Open	179.40
Previous Close	178.54
Day's Range	178.50 - 181.15
52-Week Range	171.69 - 256.85
Beta	undefined

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the wit...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Mar 17, 1980

Employees 14,500

Stock Exchange NYSE

Ticker Symbol TFX

Website https://www.teleflex.com

Analyst Forecast

According to 7 analyst ratings, the average rating for TFX stock is "Buy." The 12-month stock price forecast is $247.5, which is an increase of 38.28% from the latest price.

Buy 57.14%

Hold 42.86%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Teleflex is scheduled to release its earnings on Feb 20, 2025, before market opens.
Analysts project revenue of $824.98M, reflecting a 6.60% YoY growth and earnings per share of 3.95, making a 16.86% increase YoY.

Why Price Moved

2 months ago · Source

-14.52%

Teleflex shares are trading lower after the compan... Unlock content with Pro Subscription

10 months ago · Source

-5.28%

Teleflex shares are trading lower after the company reported Q4 financial results and issued FY24 EPS guidance below estimates.

News

1 week ago · businesswire.com

Glancy Prongay & Murray LLP Announces Investigation of Teleflex Incorporated (TFX)

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Teleflex Incorporated (NYSE: TFX) concerning the Company and its directors' and officers' possible violati...

3 weeks ago · zacks.com

Here's Why Teleflex (TFX) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

3 weeks ago · zacks.com

Should You Retain Teleflex Stock in Your Portfolio Right Now?

TFX stays on investors' radars due to its performance in the Vascular Access segment and expansion moves.

1 month ago · zacks.com

Teleflex Expands CVC Portfolio in EMEA With New Launch: Stock to Gain?

Teleflex introduces the Arrowg+ard Blue Plus MSB Procedure Kit in the EMEA.

1 month ago · zacks.com

Why Teleflex (TFX) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 month ago · zacks.com

Here's Why Teleflex (TFX) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

2 months ago · zacks.com

Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook

TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments.

2 months ago · seekingalpha.com

Teleflex Incorporated (TFX) Q3 2024 Earnings Call Transcript

Teleflex Incorporated (NYSE:TFX ) Q3 2024 Results Conference Call October 31, 2024 8:00 AM ET Company Participants Lawrence Keusch - Vice President-Investor Relations & Strategy Development Liam Kelly...

2 months ago · zacks.com

Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Str...

2 months ago · zacks.com

Teleflex (TFX) Surpasses Q3 Earnings Estimates

Teleflex (TFX) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.38 per share. This compares to earnings of $3.64 per share a year ago.

2 months ago · reuters.com

Teleflex beats quarterly profit estimates on robust medical devices demand

Surgical equipment maker Teleflex reported a better-than-expected profit for the third quarter on Thursday, helped by strong demand for its medical devices.

2 months ago · zacks.com

TFX Stock to Gain From Launch of New Vascular Access Devices in Canada

Teleflex launches the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet in Canada.

2 months ago · zacks.com

Earnings Preview: Teleflex (TFX) Q3 Earnings Expected to Decline

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago · zacks.com

TFX or EW: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Instruments stocks have likely encountered both Teleflex (TFX) and Edwards Lifesciences (EW). But which of these two companies is the best option for those look...